LPL Financial LLC Boosts Position in HealthEquity, Inc. (NASDAQ:HQY)

LPL Financial LLC boosted its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.8% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,256 shares of the company's stock after buying an additional 4,451 shares during the period. LPL Financial LLC's holdings in HealthEquity were worth $4,211,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the 4th quarter valued at approximately $26,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after buying an additional 98 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of HealthEquity by 65.6% during the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after buying an additional 164 shares during the period. Skandinaviska Enskilda Banken AB publ lifted its stake in shares of HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock worth $45,000 after buying an additional 445 shares during the period. Finally, Lindbrook Capital LLC grew its holdings in shares of HealthEquity by 27.6% during the fourth quarter. Lindbrook Capital LLC now owns 750 shares of the company's stock valued at $72,000 after buying an additional 162 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company's stock.

Remove Ads

HealthEquity Stock Performance

NASDAQ HQY traded up $0.08 during mid-day trading on Tuesday, reaching $83.44. 104,073 shares of the stock were exchanged, compared to its average volume of 758,821. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The business's 50 day moving average is $97.05 and its 200-day moving average is $96.45. The company has a market capitalization of $7.22 billion, a P/E ratio of 76.57, a P/E/G ratio of 1.60 and a beta of 0.49.

Insiders Place Their Bets

In other news, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. The trade was a 13.55 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Robert W. Selander sold 5,750 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,381 shares of company stock worth $1,781,432. Company insiders own 2.20% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on HQY shares. The Goldman Sachs Group lowered their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Barrington Research reaffirmed an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a report on Friday. Wells Fargo & Company increased their price target on shares of HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. KeyCorp reduced their price target on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Monday, March 24th. Finally, Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price objective for the company from $120.00 to $115.00 in a report on Tuesday, March 25th. One equities research analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, HealthEquity has a consensus rating of "Buy" and an average price target of $112.58.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.